Jianxun Song

OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation.

The costimulation-regulated duration of PKB activation controls T cell longevity.

Deficiency of the cyclin kinase inhibitor p21(WAF-1/CIP-1) promotes apoptosis of activated/memory T cells and inhibits spontaneous systemic autoimmunity.

Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion.

Protein kinase C-theta is an early survival factor required for differentiation of effector CD8+ T cells.

Signals from OX40 regulate nuclear factor of activated T cells c1 and T cell helper 2 lineage commitment.

The kinases aurora B and mTOR regulate the G1-S cell cycle progression of T lymphocytes.

Cooperation between CD4 and CD8 T cells for anti-tumor activity is enhanced by OX40 signals.

Activation of NF-kappaB1 by OX40 contributes to antigen-driven T cell expansion and survival.

Intracellular signals of T cell costimulation.

Cooperation between molecular targets of costimulation in promoting T cell persistence and tumor regression.

T lineage differentiation from induced pluripotent stem cells.

FoxP3 and Bcl-xL cooperatively promote regulatory T cell persistence and prevention of arthritis development.

In vivo programming of tumor antigen-specific T lymphocytes from pluripotent stem cells to promote cancer immunosurveillance.

The regulation of FoxP3-expressing regulatory T cells.

Global mapping of H3K4me1 and H3K4me3 reveals the chromatin state-based cell type-specific gene regulation in human Treg cells.

USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development.

Programming of regulatory T cells from pluripotent stem cells and prevention of autoimmunity.

Transgenic expression of survivin compensates for OX40-deficiency in driving Th2 development and allergic inflammation.

Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis.

Regulation of A1 by OX40 contributes to CD8(+) T cell survival and anti-tumor activity.

Telbivudine treatment corrects HBV-induced epigenetic alterations in liver cells of patients with chronic hepatitis B.

The serine-threonine kinase Inositol-requiring enzyme 1 α (IRE1α) promotes IL-4 production in T helper cells.

Comparative effects of pulsatile and nonpulsatile flow on plasma fibrinolytic balance in pediatric patients undergoing cardiopulmonary bypass.

A new consumable anode material of titanium oxycarbonitride for the USTB titanium process.

Utilizing regulatory T cells against rheumatoid arthritis.

Modulation of autoimmune diseases by iPS cells.

Apolipoprotein E levels in pediatric patients undergoing cardiopulmonary bypass.

Laboratory Evaluation of Hemolysis and Systemic Inflammatory Response in Neonatal Nonpulsatile and Pulsatile Extracorporeal Life Support Systems.

Innate Lymphoid Cells: A Promising New Regulator in Fibrotic Diseases.

Deleted in Breast Cancer 1 Suppresses B Cell Activation through RelB and Is Regulated by IKKα Phosphorylation.

Impact of Pulsatile Flow on Vital Organ Recovery During Cardiopulmonary Bypass in Neonates and Infants.

Melanoma Immunotherapy in Mice Using Genetically Engineered Pluripotent Stem Cells.

C-Myc regulation by costimulatory signals modulates the generation of CD8+ memory T cells during viral infection.

Stem cell-derived tissue-associated regulatory T cells ameliorate the development of autoimmunity.

TGF-β-Induced Regulatory T Cells Directly Suppress B Cell Responses through a Noncytotoxic Mechanism.

The influence of fluoride ions on the equilibrium between titanium ions and titanium metal in fused alkali chloride melts.

The ER membrane-anchored ubiquitin ligase Hrd1 is a positive regulator of T-cell immunity.

Endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 controls B-cell immunity through degradation of the death receptor CD95/Fas.

Development of Auto Antigen-specific Regulatory T Cells for Diabetes Immunotherapy.

Protective Cancer Vaccine Using Genetically Modified Hematopoietic Stem Cells.

Generation of Tumor Antigen-Specific Cytotoxic T Lymphocytes from Pluripotent Stem Cells.

Adoptive Cell Transfer: Is it a Promising Immunotherapy for Colorectal Cancer?

Stem cell-derived tissue-associated regulatory T cells suppress the activity of pathogenic cells in autoimmune diabetes.

Identification of a small-molecule compound that inhibits homodimerization of oncogenic NAC1 protein and sensitizes cancer cells to anticancer agents.

In Vitro Differentiation of T Cells from Murine Pluripotent Stem Cells.

Targeting Stem Cell-Derived Tissue-Associated Regulatory T Cells for Type 1 Diabetes Immunotherapy.